MMP9 and cancer: However, in vivo studies in mouse cancer models suggest that TSPAN8 enhances cancer cell motility and migration mainly by recruiting integrins, whereas CD151 efficiently recruits and activates MMP9 and MMP13 to facilitate the degradation of the ECM and the invasion of tumor cells [92,93,101,136].